LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

Kodu・Aktsiate loetelu・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Suletud

SektorTervishoid

27.86 0.04

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

27.08

Max

28.12

Põhinäitajad
By Trading Economics
Sissetulek	-28M 22M
Müük	4.3M 244M
P/E Sektori keskmine	10.28 57.833
Aktsiakasum	1.08
Kasumimarginaal	9.224
Töötajad	293
EBITDA	-22M 52M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+48.11% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	5. mai 2026

Turustatistika
By TradingEconomics
Turukapital	64M 1.6B
Eelmine avamishind	27.82
Eelmine sulgemishind	27.86

Uudiste sentiment

By Acuity

75%

25%

322 / 350 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

29.8 / N/A Toetus ja vastupanu

Harmony Biosciences Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

19. märts 2026, 18:34 UTC

Tulu

Canada to Allow Smaller Companies to Ax Quarterly Earnings Reports in Pilot

19. märts 2026, 17:43 UTC

Suurimad hinnamuutused turgudel

Ecolab Dips on Report of Deal for CoolIT Systems With KKR

19. märts 2026, 23:47 UTC

Tulu

COSCO SHIPPING Holdings: Geopolitical Tensions Will Continue Driving Regional Fragmentation >1919.HK

19. märts 2026, 23:47 UTC

Tulu

COSCO SHIPPING Holdings: Container Shipping Market Saw Fluctuating, Declining Freight Rates >1919.HK

19. märts 2026, 23:47 UTC

Tulu

COSCO SHIPPING Holdings 2025 Rev CNY219.50B Vs. CNY233.86B >1919.HK

19. märts 2026, 23:47 UTC

Tulu

COSCO SHIPPING Holdings 2025 Net CNY30.86B Vs. Net CNY49.17B >1919.HK

19. märts 2026, 23:39 UTC

Tulu

Li Ning 2025 Net CNY2.94B Vs. Net CNY3.01B >2331.HK

19. märts 2026, 23:39 UTC

Tulu

Li Ning: Will Continue Targeting Consumer Needs, Strengthening User Engagement >2331.HK

19. märts 2026, 23:39 UTC

Tulu

Li Ning: Outdoor Category Continued Growing >2331.HK

19. märts 2026, 23:38 UTC

Tulu

Li Ning 2025 Rev CNY29.60B Vs. CNY28.68B >2331.HK

19. märts 2026, 23:33 UTC

Market Talk

Gold Edges Lower on Inflation Concerns, Dimmed Fed Rate-Cut Hopes -- Market Talk

19. märts 2026, 22:42 UTC

Omandamised, ülevõtmised, äriostud

Unilever in Talks to Separate Food Business and Combine It With McCormick -- WSJ

19. märts 2026, 22:42 UTC

Omandamised, ülevõtmised, äriostud

McCormick Has a Market Value of Around $14.8B -- WSJ

19. märts 2026, 22:42 UTC

Omandamised, ülevõtmised, äriostud

Unilever in Talks to Combine Food Business With McCormick, Sources Say -- WSJ

19. märts 2026, 22:42 UTC

Omandamised, ülevõtmised, äriostud

All-Stock Unilever-McCormick Deal Could Come Together Within Weeks, Sources Say -- WSJ

19. märts 2026, 22:23 UTC

Market Talk

FedEx Says It Can Raise Prices to Offset Higher Fuel Costs -- Market Talk

19. märts 2026, 22:09 UTC

Market Talk

Uudisväärsed sündmused

Australian Transport Stocks to Trade at Discount On Fuel Risks -- Market Talk

19. märts 2026, 22:06 UTC

Market Talk

Sigma Healthcare's New Bull Expects Profit Margins to Widen -- Market Talk

19. märts 2026, 22:04 UTC

Tulu

Omandamised, ülevõtmised, äriostud

FedEx CFO: MD-11 Grounding Led to $120M Headwind to Adjusted Operating Income in 3Q

19. märts 2026, 22:03 UTC

Market Talk

Uudisväärsed sündmused

Global Energy Roundup: Market Talk

19. märts 2026, 22:03 UTC

Market Talk

Uudisväärsed sündmused

Fuel Prices, Scarcity Could Leave Mark on Australia's Gold Miners -- Market Talk

19. märts 2026, 21:51 UTC

Tulu

Omandamised, ülevõtmised, äriostud

FedEx CEO: InPost Deal Expected to Be Accretive to Earnings in Year One After Close

19. märts 2026, 20:57 UTC

Uudisväärsed sündmused

Middle East Attacks, Inflation Fears Weigh on Stocks -- WSJ

19. märts 2026, 20:50 UTC

Market Talk

Uudisväärsed sündmused

Basic Materials Roundup: Market Talk

19. märts 2026, 20:19 UTC

Uudisväärsed sündmused

Brent Crude Retreats After Touching $119 -- WSJ

19. märts 2026, 19:49 UTC

Market Talk

Brent Crude Seen Potentially Rising to Top Its 2008 High -- Market Talk

19. märts 2026, 19:26 UTC

Uudisväärsed sündmused

U.S. Consumers Face 'Global Oil Shock.' The Iran War Is Retail's Latest Challenge. -- Barrons.com

19. märts 2026, 19:10 UTC

Market Talk

Uudisväärsed sündmused

Natural Gas Rises in Volatile Trading -- Market Talk

19. märts 2026, 19:06 UTC

Uudisväärsed sündmused

Brent Crude Prices Are Surging. Why Europe Is Facing an Energy Shock and the U.S. Isn't. -- Barrons.com

19. märts 2026, 18:08 UTC

Market Talk

Uudisväärsed sündmused

Silver Extends Slide to Seven Straight Sessions -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Harmony Biosciences Holdings Inc Prognoos

Hinnasiht

By TipRanks

48.11% tõus

12 kuu keskmine prognoos

Keskmine 41.25 USD 48.11%

Kõrge 62 USD

Madal 25 USD

Põhineb 8 Wall Streeti analüütiku instrumendi Harmony Biosciences Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

8 ratings

Osta

Hoia

Müü

Põhineb 8 analüütiku instrumendi Harmony Biosciences Holdings Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

29.8 / N/AToetus ja vastupanu

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

322 / 350 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.